Welch Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Buy
15,064
+7,415
+97% +$7.58M 0.62% 39
2026
Q1
$7.04M Sell
7,649
-37
-0.5% -$37.5K 0.26% 58
2025
Q4
$8.26M Buy
7,686
+172
+2% +$164K 0.32% 53
2025
Q3
$5.73M Buy
7,514
+1,004
+15% +$747K 0.22% 59
2025
Q2
$5.07M Buy
6,510
+75
+1% +$58.3K 0.21% 59
2025
Q1
$5.29M Sell
6,435
-65
-1% -$54.1K 0.23% 56
2024
Q4
$5.03M Sell
6,500
-48
-0.7% -$39.7K 0.23% 59
2024
Q3
$5.8M Buy
6,548
+209
+3% +$188K 0.25% 56
2024
Q2
$5.74M Buy
6,339
+398
+7% +$318K 0.28% 53
2024
Q1
$4.62M Buy
5,941
+642
+12% +$457K 0.23% 56
2023
Q4
$3.09M Sell
5,299
-218
-4% -$127K 0.17% 62
2023
Q3
$2.96M Buy
5,517
+48
+0.9% +$24.7K 0.18% 60
2023
Q2
$2.56M Sell
5,469
-256
-4% -$107K 0.15% 60
2023
Q1
$1.97M Sell
5,725
-144
-2% -$48.6K 0.11% 65
2022
Q4
$2.15M Buy
5,869
+45
+0.8% +$16K 0.12% 68
2022
Q3
$1.88M Sell
5,824
-610
-9% -$193K 0.12% 63
2022
Q2
$2.09M Hold
6,434
0.13% 63
2022
Q1
$1.84M Buy
6,434
+490
+8% +$126K 0.11% 72
2021
Q4
$1.64M Sell
5,944
-188
-3% -$47.7K 0.1% 75
2021
Q3
$1.42M Hold
6,132
0.1% 72
2021
Q2
$1.41M Hold
6,132
0.1% 71
2021
Q1
$1.15M Buy
6,132
+851
+16% +$166K 0.08% 74
2020
Q4
$892K Buy
5,281
+574
+12% +$85.7K 0.07% 76
2020
Q3
$697K Sell
4,707
-100
-2% -$15.5K 0.06% 79
2020
Q2
$789K Buy
4,807
+1,102
+30% +$169K 0.07% 69
2020
Q1
$514K Buy
3,705
+1,560
+73% +$214K 0.05% 75
2019
Q4
$282K Buy
2,145
+355
+20% +$41.1K 0.03% 105
2019
Q3
$200K Hold
1,790
0.02% 111
2019
Q2
$198K Sell
1,790
-35
-2% -$4.12K 0.02% 108
2019
Q1
$237K Buy
1,825
+670
+58% +$81.5K 0.03% 112
2018
Q4
$134K Buy
1,155
+8
+0.7% +$894 0.02% 126
2018
Q3
$123 Buy
+1,147
New +$115K 0.01% 140
2013
Q3
Sell
-198,934
Closed -$9.77M 127
2013
Q2
$9.77M Buy
+198,934
New +$10.8M 2.54% 29

Other funds holding LLY

Welch Group's LLY Position: Q2 2026 in Review

Welch Group increased its Eli Lilly (LLY) stake by 97% in Q2 2026, buying an estimated $7.58M and bringing the position to 15,064 shares worth $18.1M. The position accounts for 0.62% of the portfolio, ranked #39.

Welch Group first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. 1,928 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Welch Group held 15,064 shares of Eli Lilly worth $18.1M as of Q2 2026.
  • Welch Group bought 7,415 Eli Lilly shares in Q2 2026, an estimated $7.58M.
  • Eli Lilly made up 0.62% of Welch Group's portfolio in Q2 2026, its #39 holding.
  • Welch Group first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
  • 1,928 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.